SCHEMBL4432435

SCHEMBL4432435

Cc1ccc([C@@H](CCN[C@H](C(N)=O)c2ccccc2)c2ccc(F)c(C)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.49
CNR2 P34972 2/20 0.49
CASR P41180 2/20 0.45
LMNA P02545 4/20 0.42
MTNR1A P48039 3/20 0.41
MTNR1B P49286 3/20 0.41
ALDH1A1 P00352 3/20 0.40
HTT P42858 3/20 0.40
KMT2A Q03164 3/20 0.40
MITF O75030 1/20 0.40
MAPT P10636 1/20 0.40
ALOX12 P18054 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 2/20 0.40
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4434471 0.96 CNR1 (0.43) CNR1CNR2CASRLMNAMTNR1A
SCHEMBL4434660 0.89 ALOX5 (0.43) CNR1CNR2LMNAALDH1A1HTT
SCHEMBL4427996 0.89 ALOX5 (0.43) CNR1CNR2LMNAALDH1A1HTT
SCHEMBL4433690 0.87 CNR1 (0.51) CNR1CNR2CASRLMNAMTNR1A
SCHEMBL4434615 0.87 CNR1 (0.51) CNR1CNR2CASRLMNAMTNR1A
SCHEMBL4429219 0.87 CNR1 (0.51) CNR1CNR2CASRLMNAMTNR1A
SCHEMBL4432784 0.87 CNR1 (0.51) CNR1CNR2CASRLMNAMTNR1A
SCHEMBL4433145 0.83 CNR1 (0.45) CNR1CNR2CASRLMNAALDH1A1
SCHEMBL4429659 0.82 P2RX7 (0.44) LMNA
SCHEMBL4432823 0.82 P2RX7 (0.44) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114867-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. Hoffmann-Roche AG (CH) 2009-11-11 EP disclosed
WO-2008107335-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-09-12 WO disclosed